These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9298682)

  • 1. LpA-I levels do not reflect pre beta1-HDL levels in human plasma.
    Miida T; Inano K; Yamaguchi T; Tsuda T; Okada M
    Atherosclerosis; 1997 Sep; 133(2):221-6. PubMed ID: 9298682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subclasses of serum HDL in hyperlipidemia].
    Xu Y; Fu M; Liu B; Xu Y; Yao J; Zhang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):238-41. PubMed ID: 12947699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE.
    Krimbou L; Tremblay M; Davignon J; Cohn JS
    J Lipid Res; 1997 Jan; 38(1):35-48. PubMed ID: 9034198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
    Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
    Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
    Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.
    Fruchart JC; Ailhaud G
    Clin Chem; 1992 Jun; 38(6):793-7. PubMed ID: 1597003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.
    Jia L; Fu M; Tian Y; Xu Y; Gou L; Tian H; Tian L
    Int J Cardiol; 2007 Sep; 120(3):331-7. PubMed ID: 17166608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
    Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease.
    Wilson HM; Patel JC; Russell D; Skinner ER
    Clin Chim Acta; 1993 Nov; 220(2):175-87. PubMed ID: 8111962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of high-density lipoprotein subfraction HDL2 and lipoprotein A-I in a random population of healthy subjects.
    Roche D; Migueres ML; Lequang NT; Burstein M; Ekindjian OG; Girard-Globa A
    Clin Chem; 1991 Dec; 37(12):2111-3. PubMed ID: 1837246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.
    Davit-Spraul A; Atger V; Pourci ML; Hadchouel M; Legrand A; Moatti N
    J Lipid Res; 1999 Feb; 40(2):328-35. PubMed ID: 9925663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.
    Syvänne M; Kahri J; Virtanen KS; Taskinen MR
    Circulation; 1995 Aug; 92(3):364-70. PubMed ID: 7634450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
    Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of lipoprotein species (LpA-I, LpA-I:A-II) in serum and HDL subfractions of untrained and trained normolipemic men.
    Frey I; Kamps H; Baumstark MW; Berg A; Keul J
    Clin Chim Acta; 1992 Oct; 211(3):167-73. PubMed ID: 1458611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Separation of high density lipoprotein (HDL) using anti-apo A-I, apo A-II immuno-affinity chromatography to evaluate the effects of probucol].
    Kagami A; Hino K; Mochizuki K; Sakamoto T; Tada N; Ishikawa T; Manabe M; Satoh N
    Nihon Ronen Igakkai Zasshi; 1991 Nov; 28(6):748-54. PubMed ID: 1795436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I containing lipoproteins in coronary artery disease.
    Puchois P; Kandoussi A; Fievet P; Fourrier JL; Bertrand M; Koren E; Fruchart JC
    Atherosclerosis; 1987 Nov; 68(1-2):35-40. PubMed ID: 3120739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography.
    Nanjee MN; Brinton EA
    Clin Chem; 2000 Feb; 46(2):207-23. PubMed ID: 10657377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.